Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis
Inflammatory Bowel Diseases2007Vol. 14(1), pp. 88–99
Citations Over TimeTop 10% of 2007 papers
Satheesh K. Sainathan, Eyad Hanna, Qingqing Gong, Kumar S. Bishnupuri, Qizhi Luo, Marco Colonna, Francis White, Ed Croze, Courtney W. Houchen, Shrikant Anant, Brian K. Dieckgraefe
Abstract
GM-CSF is effective in the treatment of DSS colitis in a mechanism involving the 440c(+) pDC population.
Related Papers
- → Proteomic Analysis Reveals Distinct Metabolic Differences Between Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Macrophage Colony Stimulating Factor (M-CSF) Grown Macrophages Derived from Murine Bone Marrow Cells*(2015)30 cited
- → Expression of the macrophage-specific colony-stimulating factor in human monocytes treated with granulocyte-macrophage colony-stimulating factor(1987)14 cited
- → Hemopoietic colony-stimulating factors(1984)471 cited
- → Expression of the macrophage-specific colony-stimulating factor in human monocytes treated with granulocyte-macrophage colony-stimulating factor(1987)167 cited
- → Treatment intensification with interleukln-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with small-cell lung cancer(1997)